Loading...
•
Jun 30, 2024
Natera Q2 2024 Earnings Report
Natera's second quarter financial results exceeded expectations, driven by strong performance in volume, revenue, and gross margin.
Key Takeaways
Natera reported a strong second quarter with total revenues of $413.4 million, a 58.1% increase compared to the second quarter of 2023. The company processed approximately 760,300 tests and reported a net loss of $37.5 million, or ($0.30) per diluted share.
Total revenues increased by 58.1% to $413.4 million compared to Q2 2023.
Product revenues increased by 59.3% to $411.4 million compared to Q2 2023.
Approximately 760,300 tests were processed in Q2 2024, including approximately 744,000 tests accessioned in the laboratory.
Net loss for the second quarter of 2024 was $37.5 million, or ($0.30) per diluted share.
Revenue by Segment
Forward Guidance
Natera anticipates 2024 total revenue of $1.49 billion to $1.52 billion; 2024 gross margin to be approximately 54% to 56% of revenues; selling, general and administrative costs to be approximately $700 million to $750 million; research and development costs to be $350 million to $375 million; and net cash (outflow) inflow to be ($25) million to $25 million.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...